BIFULCO, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 13.771
AS - Asia 10.302
EU - Europa 5.442
SA - Sud America 518
Continente sconosciuto - Info sul continente non disponibili 317
AF - Africa 95
OC - Oceania 9
Totale 30.454
Nazione #
US - Stati Uniti d'America 13.495
HK - Hong Kong 6.084
FI - Finlandia 2.006
SG - Singapore 1.729
IT - Italia 1.212
CN - Cina 1.056
VN - Vietnam 726
UA - Ucraina 629
RU - Federazione Russa 408
BR - Brasile 378
DE - Germania 315
SE - Svezia 223
IE - Irlanda 211
TR - Turchia 194
FR - Francia 162
CA - Canada 138
KR - Corea 125
IN - India 109
GB - Regno Unito 84
AR - Argentina 56
BD - Bangladesh 55
IQ - Iraq 43
MX - Messico 42
ES - Italia 38
JP - Giappone 31
NL - Olanda 30
PL - Polonia 29
ZA - Sudafrica 29
CZ - Repubblica Ceca 27
PK - Pakistan 23
CR - Costa Rica 22
JM - Giamaica 21
VE - Venezuela 20
ID - Indonesia 18
CO - Colombia 16
UZ - Uzbekistan 15
EC - Ecuador 13
DZ - Algeria 10
MA - Marocco 10
SA - Arabia Saudita 10
AT - Austria 9
HN - Honduras 9
KE - Kenya 9
LT - Lituania 9
BE - Belgio 8
BO - Bolivia 8
CH - Svizzera 8
CL - Cile 8
IL - Israele 8
LB - Libano 8
MY - Malesia 8
PY - Paraguay 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
JO - Giordania 7
SV - El Salvador 7
BB - Barbados 6
NP - Nepal 6
PE - Perù 6
PH - Filippine 6
PR - Porto Rico 6
AU - Australia 5
EG - Egitto 5
ET - Etiopia 5
GT - Guatemala 5
NI - Nicaragua 5
PA - Panama 5
TW - Taiwan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
GR - Grecia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LC - Santa Lucia 3
MD - Moldavia 3
RO - Romania 3
UY - Uruguay 3
AO - Angola 2
CM - Camerun 2
GY - Guiana 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
LY - Libia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
Totale 30.122
Città #
Hong Kong 6.079
Dallas 2.971
Ann Arbor 2.161
Helsinki 1.875
San Jose 1.034
Chandler 900
Singapore 874
Jacksonville 756
Princeton 590
Ashburn 553
Woodbridge 540
Milan 435
Dong Ket 424
Wilmington 395
Council Bluffs 331
Houston 319
Dublin 211
Nanjing 194
Beijing 193
Izmir 170
Boardman 139
Lauterbourg 135
The Dalles 134
Andover 132
Pellezzano 118
Munich 116
Ho Chi Minh City 100
Rome 96
Santa Clara 88
Los Angeles 81
Salerno 81
Hanoi 75
Moscow 69
New York 65
Nanchang 55
Shenyang 55
Fairfield 54
São Paulo 48
Hebei 46
Jiaxing 44
Norwalk 42
Mestre 40
Changsha 36
Figino 36
Naples 34
Orem 32
Pune 31
Tokyo 30
Turin 28
Brooklyn 27
Memphis 27
Tianjin 27
Warsaw 27
Phoenix 26
Chicago 25
Denver 25
Amsterdam 24
Atlanta 23
Brno 23
Montreal 23
Seattle 22
Shanghai 22
Frankfurt am Main 21
Johannesburg 21
San Francisco 21
Baghdad 19
Dearborn 19
Düsseldorf 19
Jinan 19
London 19
Mexico City 19
Stockholm 19
Toronto 19
Turku 19
San Diego 18
San José 18
Washington 18
Boston 17
Columbus 17
Da Nang 15
Chennai 14
Kingston 14
Haiphong 13
Manchester 13
Newark 13
Nuremberg 13
Seoul 13
Brasília 12
Florence 12
Qualiano 12
Redwood City 12
West Jordan 12
Zhengzhou 12
Cambridge 11
Tashkent 11
Buffalo 10
Mumbai 10
Poplar 10
Bari 9
Curitiba 9
Totale 23.938
Nome #
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 4.815
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 1.525
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 1.059
The endocannabinoid signaling system in cancer 902
Concomitant BRAFV600E mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. 580
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 538
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. 507
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 353
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 353
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 340
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 305
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 283
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 283
Identification of CM223 as a new ligand of farnesyl pyrophosphate synthase with improved antiglioma action 263
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 254
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 235
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 235
The medieval skincare routine according to the formulations of Madgistra Trotula and the Medical School of Salerno and its reflection on cosmetology of the third millennium 220
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 218
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 215
Dental care and dentistry practice in the Medieval Medical School of Salerno 207
Binding of the hemopressin peptide to the cannabinoid CB(1) receptor: structural insights. 204
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 200
Cannabidiol: State of the art and new challenges for therapeutic applications 190
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 184
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 183
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines 181
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. 177
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 177
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 172
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 172
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 171
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 170
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells 170
Brain cancer risk: the weight of obesity 165
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 164
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 164
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 163
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A 162
What we know and do not know about the cannabinoid receptor 2 (CB2) 159
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 155
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 151
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 151
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 150
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 150
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 150
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 148
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 146
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 145
Thyroid adiponcosis: more than an hypothesis 144
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 142
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 142
A new role of anandamide in human sperm: focus on metabolism 142
Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in the rat: direct role of cholesterol. 140
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 139
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 138
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells 138
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation 136
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 133
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 133
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 132
The basis of the modern medical hygiene in the medieval Medical School of Salerno 132
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 132
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 131
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 131
A focus on Trotula de' Ruggiero: A pioneer in women's and children's health in history of medicine 130
Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: Killing two birds with one stone 129
Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency 128
Updates on Adiponcosis: More new incoming evidence strengthening the obesity-cancer link 127
The right to care and the expectations of society?controversial stem cell therapy in Italy 126
Breast adiponcosis: a call for further research 125
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 124
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 124
Statins and cancer-related mortality: an open question. 124
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 124
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 124
v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: multiple interference with the isoprenoid pathway 123
Statins and cancer in gastroenterology: new insight? 122
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 121
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities 121
Cannabinoids and cancer: pros and cons of an antitumour strategy. 120
Mediterranean diet: The missing link between gut microbiota and inflammatory diseases 119
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 118
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin 117
Cannabinoid receptor CB1 antagonists state of the art and challenges 116
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 116
Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways 114
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 114
Statins in neurological disorders: an overview and update 112
Novel prospects of statins as therapeutic agents in cancer 112
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 111
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 111
End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion. 109
N6-ISOPENTENYLADENOSINE IS A POTENT PRO-APOPTOTIC AGENT IN THE THYROID CELL 108
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 107
Comment on 'When in Rome, reform'. 107
Antibiotics exposure in obesity: an update of a complex relationship 107
Multifaceted role of PRDM proteins in human cancer 107
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases 106
The Endocannabinoid System: A Target for Cancer Treatment 105
Totale 24.657
Categoria #
all - tutte 83.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.018 0 0 0 14 53 14 3 47 141 145 147 454
2022/20231.870 173 145 14 278 271 382 10 184 262 13 82 56
2023/2024670 68 105 42 30 48 114 14 28 8 35 49 129
2024/20251.870 116 27 106 99 79 184 310 170 269 70 204 236
2025/202616.363 2.521 3.062 3.814 446 809 396 1.083 252 2.356 749 162 713
2026/20271.630 207 190 473 760 0 0 0 0 0 0 0 0
Totale 30.454